Kobe City and Medicaroid announced their collaboration and cooperation toward the development and social implementation of automated PCR testing robot systems in preparation for the next wave of the new coronavirus pandemic (COVID-19).
The said organizations are working toward the social implementation of automated PCR testing robot systems along with monitoring/care networks to reduce the medical personnel's risk of infection and workload as well as contribute to the expansion of PCR testing systems.
The following three robot systems will be provided: a remote-controlled sample collection robot system, an automatic PCR testing robot system, and a monitoring/care network system that delivers meals and performs vital measurements such as temperature.
Kobe City is in charge of coordinating with hospitals and lodging/recuperation facilities for social implementation, co-support via the coordinator of the Foundation for Biomedical Research and Innovation at Kobe (FBRI), and financial support for development expenses. This endeavor is expected to reduce the medical personnel's risk of infection and workload as well as contribute to the expansion of the number of PCR testing systems.
As for their future schedule, the organizations plan to design, manufacture, and evaluate the robot systems from June to September, and begin operations at facilities in the KOBE Biomedical Innovation Cluster in October.
Medicaroid was born from the investments of Sysmex and Kawasaki Heavy Industries. Kawasaki Heavy Industries is a company that owns robot technology, while Sysmex is known for its medical testing equipment technology and wide network in the medical industry. The origin of the company name Medicaroid comes from combining the words Medical and Android, in other words, Medical Robot.